This invention relates to swallowable tablets containing at least 80% by weight of N acetylcysteine (NAC) and at least one pharmaceutically acceptable excipient in particular tablets in which the sulfurous odor is absent characterized in that the said tablets are assembled using a granulate prepared by means of a process of dry granulating the active ingredient alone with which the excipients are mixed before compression.
